Some experts claim that reducing fluctuations throughout the day can help protect against heart disease, even for people who ...

Glucotrack has successfully completed a first-in-human study with its continuous glucose monitor (CGM) that directly measures ...

DexCom (NASDAQ: DXCM) is a healthcare company that makes continuous glucose monitoring (CGM) devices, which help people track ...

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

The use of a continuous glucose monitor during pregnancy may be more cost-effective than self-monitoring blood glucose for ...

Completing the CE Mark submission for Eversense 365 brings us a step closer to improving lives and health outcomes for ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms can overlap between diabetes and dementia.

The latest analysis confirms that first-day accuracy - a critical performance metric for CGM users - shows an approximately 35% improvement in Mean Absolute Relative Difference (MARD) and a more than ...

Medical device specialist DexCom (NASDAQ: DXCM) has substantially underperformed the market over the trailing-12-month period. The diabetes-focused company disappointed investors last year due to ...

Smart watches, rings, and a growing array of patches are adding more functionality and being used across a growing set of ...

Continuous glucose monitors, or CGMs, are small devices that track blood sugar in real time and can tell wearers how their bodies are reacting to stress, food, sleep or exercise. New versions ...

Is there a benefit for healthy people to track their blood sugar? Measuring blood sugar has joined sleep and exercise tracking as wellness trends, with some longevity experts claiming that ...